(Q35777408)

10 August 2017

1 reference

title

High-density lipoproteins: multifunctional vanguards of the cardiovascular system (English)

1 reference

10 August 2017

4

Jacques Genest

1 reference

10 August 2017

Michel Marcil

1

1 reference

10 August 2017

Brian O'Connell

series ordinal

2

1 reference

10 August 2017

Larbi Krimbou

series ordinal

3

1 reference

10 August 2017

publication date

1 May 2004

1 reference

Expert Review of Cardiovascular Therapy

10 August 2017

published in

1 reference

10 August 2017

volume

2

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

417-430

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Atheroprotective effects of high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

High-density lipoproteins and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Familial lipoprotein disorders in patients with premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Expression, regulation, and activity of ABCA1 in human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Lipoprotein disorders and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

The effects of altered apolipoprotein A-I structure on plasma HDL concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Cholesterol in the year 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Characterization of LDL particle size among carriers of a defective or a null mutation in the lipoprotein lipase gene: the Québec LIPD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Metabolism of High-Density Lipoprotein Apolipoproteins in Tangier Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

High-density lipoprotein increases intracellular calcium levels by releasing calcium from internal stores in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Interaction of lecithin:cholesterol acyltransferase (LCAT).alpha 2-macroglobulin complex with low density lipoprotein receptor-related protein (LRP). Evidence for an alpha 2-macroglobulin/LRP receptor-mediated system participating in LCAT clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Prevention of cardiovascular ischemic events: high-risk and secondary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

The HDL receptor SR-BI: a new therapeutic target for atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Killing of trypanosomes by the human haptoglobin-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.3.417

21 January 2018

Identifiers

DOI

10.1586/14779072.2.3.417

1 reference

10 August 2017

1 reference